bannerHON
img
HONnews
HONnews
img PATIENT / PARTICULIER img PROFESSIONNEL DE SANTE img WEBMESTRE img
img
 
img
HONcode sites
Khresmoi - new !
HONselect
News
Conferences
Images

Themes:
A B C D E F G H I
J K L M N O P Q
R S T U V W X Y Z
Browse archive:
2017: D N O S A J J M A M F J
2016: D

 
  Other news for:
Infection
Acquired Immunodeficiency Syndrome
Sexually Transmitted Diseases
Syphilis
 Resources from HONselect
Can HIV Drugs Boost Syphilis Risk?
Meds may raise susceptibility to bacterium that causes the sexually transmitted disease, study suggests

By Robert Preidt

MONDAY, Jan. 16, 2017 (HealthDay News) -- Gay and bisexual men taking antiretroviral drugs to treat HIV infection may be at increased risk for syphilis, new research contends.

Based on a review of available evidence, the investigators concluded that the drugs may boost susceptibility to the bacterium that causes syphilis, although the study did not prove cause-and-effect.

The finding might explain why new and repeat cases of syphilis in gay and bisexual men have risen sharply compared to other sexually transmitted infections over the past decade, the researchers wrote.

The study team was led by Dr. Michael Rekart, from the University of British Columbia's School of Population and Public Health in Vancouver. The findings were published in the Jan. 16 issue of the journal Sexually Transmitted Infections.

The authors of an editorial that accompanied the study said the theory is "intriguing" and "warrants careful consideration." But the editorial also suggested that the increase in syphilis cases among gay and bisexual men may be due to other factors.

"We are living in an era where [antiretroviral therapy] is being used to effectively treat and prevent HIV infection. To some extent this seems to have tempered the urgency to control other [sexually transmitted infections]. As history has shown many times over, that would be a costly mistake," said Susan Tuddenham, Maunank Shah and Khalil Ghanem, from Johns Hopkins University School of Medicine in Baltimore.

"Over the past 15 years, syphilis rates among [gay and bisexual men] have been rising unabated," Tuddenham and colleagues noted in a journal news release.

"If further investigations support a role for [antiretroviral therapy] in increasing susceptibility to syphilis, this will provide one more reason why screening, diagnosis and treatment of [sexually transmitted infections] in [gay and bisexual men] must be prioritized," the editorial concluded.

More information

The U.S. National Institute of Allergy and Infectious Diseases has more on syphilis.

SOURCE: Sexually Transmitted Infections, news release, Jan. 16, 2017

Copyright © 2017 HealthDay. All rights reserved. URL:http://consumer.healthday.com/Article.asp?AID=718665

Resources from HONselect: HONselect is the HON's medical search engine. It retrieves scientific articles, images, conferences and web sites on the selected subject.
Syphilis
Infection
Specialty Chemicals and Products
Risk
Men
Research Personnel
HIV Infections
The list of medical terms above are retrieved automatically from the article.

Disclaimer: The text presented on this page is not a substitute for professional medical advice. It is for your information only and may not represent your true individual medical situation. Do not hesitate to consult your healthcare provider if you have any questions or concerns. Do not use this information to diagnose or treat a health problem or disease without consulting a qualified healthcare professional.
Be advised that HealthDay articles are derived from various sources and may not reflect your own country regulations. The Health On the Net Foundation does not endorse opinions, products, or services that may appear in HealthDay articles.


Inicio img Sobre nosotros img Rincón de la prensa img Boletín HON img Mapa del sitio img Política ética img Contactos